OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Trustees’ Annual Report 2025

UK Acute Oncology Society (UKAOS)

Charity registration number: 1199351

Legal form: Charitable Incorporated Organisation (CIO) Reporting period: [insert start date] to [insert end date] Gross income: Less than £25,000

Principal office: UKAOS Secretariat, c/o Media1 Productions Ltd, Clarence Mill, Clarence Road, Bollington, Macclesfield SK10 5JZ

Reference and administrative details

Trustees who served during the reporting period:

Structure, governance and management

UKAOS is a Charitable Incorporated Organisation governed by its constitution dated 16 June 2022 and updated on 18 January 2025. The Board of Trustees is responsible for the charity’s strategic direction, financial stewardship, legal compliance and oversight of risk.

Trustee appointment, induction and organisation

Trustees are appointed in accordance with the constitution, having regard to the skills, experience and diversity of perspective required by the Board. New trustees receive appropriate induction on the charity’s purposes, governing document, trustee duties, finances and current priorities.

How the charity is managed

1

Objectives and activities

Charitable purposes

Public benefit

The trustees have had due regard to the Charity Commission’s guidance on public benefit when planning and delivering the charity’s work.

UKAOS advances education for healthcare professionals involved in acute oncology, promotes research and dissemination of useful findings, and supports improvements in the treatment, care and wellbeing of people affected by cancer and the acute effects of cancer treatment.

During the year, the charity delivered public benefit through:

Achievements and performance

The charity’s principal achievements during the year are summarised under six strategic themes.

2

  1. Publications and guidance. Published the first five-year UKAOS strategy; launched a four-nation review of 24/7 systemic anti-cancer therapy helplines; published initial Same Day Emergency Care pathways for unexpected pulmonary embolism, metastatic spinal cord compression and low-risk febrile neutropenia; and progressed reviews of malignancy of unknown origin services and acute oncology in emergency departments.

  2. Education. Delivered the UKAOS annual conference and established the online Learning Hour programme, alongside contributions to national oncology and systemic anti-cancer therapy events.

  3. Urgent cancer care data. Continued work to improve reporting through the Cancer Outcomes and Services Dataset and CancerStats2, and secured a national partnership with Macmillan Cancer Support and the National Disease Registration Service to investigate urgent-care use among people with lung cancer receiving systemic anti-cancer therapy.

  4. Governance and policy. Completed a governance review, established an Operational Steering Group and continued to develop policies and procedures to support effective oversight.

  5. Income generation. Explored fundraising opportunities to strengthen the charity’s education and service-improvement work.

  6. National policy. Supported the inclusion of a commitment to develop acute and supportive oncology quality standards within national cancer policy.

Financial review

The charity’s gross income for the reporting period was less than £25,000. Full details of receipts, payments, assets and liabilities are set out in the annual accounts approved by the trustees.

Reserves: The charity did not have a formally approved reserves policy at the reporting date. The trustees will develop and approve an appropriate policy during 2026, taking account of planned commitments, financial risks and the need for operational continuity.

Going concern: Having reviewed available funds and anticipated commitments, the trustees consider that the charity has adequate resources to continue its activities for the foreseeable future, subject to confirmation when approving the accounts.

3

Debts and custodian funds: “The charity had no material debts and held no funds as custodian trustee at the year end.”]

Risk management and trustee

responsibilities

The trustees regularly consider the principal risks facing the charity and take proportionate steps to manage them. These include financial sustainability, governance capacity, data protection, reputation and delivery of activities through partners or volunteers.

The trustees are responsible for maintaining proper accounting records, safeguarding the charity’s assets, preparing annual accounts and a trustees’ annual report, and ensuring that the charity acts in accordance with its constitution and applicable law.

Serious incidents: No serious incidents requiring a report to the Charity Commission were identified

Plans for the next reporting period

Approval and declaration

This report was approved by the Board of Trustees on [insert date] and signed on its behalf by:

Ernest Marshall, Chair

4

Signature: _ ___ Date: __02/09/2026__

5

2025

⚖
CHARITY COMMISSION
FOR ENGLAND AND WALES
CharityName CharityName
UK Acute Oncology Society (UKAOS)
For the period
from
Period start date
1-Jan-25

Section A Receipts and payments

Unrestricted Restricted funds funds to the nearest £ to the nearest £

A1 Receipts

A1 Receipts
Sponsorships and grants 25,000
Sub total (Gross income for
AR)
25,000 -
Funds received in error 0
Sub total 0 -
Total receipts 25,000
A3 Payments
Bank charges 240
Website expenses 1473
Secretariat 6,708
Accountancy 924
Repayment for funds received in
error
0
Sub total 9,345 -
Sub total -
Total payments 9,345 -
Net of receipts/(payments) 15,655 -
A5 Transfers between funds 4,755
A6 Cash funds last year end 20,410 -

Section B Statement of assets and liabilities at the end of the period

Categories Details B1 Cash funds Bank

B2
Other monetary assets
B3
Investment assets
Details
Details

Details

B4

Assets retained for the charity's own use

Details

B5

Signed by one or two trustees on behalf of all the trustees

Liabilities

Signa

CCXX R2 accounts (SS)

No (if any) 1199351 Receipts and payments accounts Period end date To 31-Dec-25

Endowment
Total funds
funds
to the nearest £
to the nearest £
Endowment
Total funds
funds
to the nearest £
to the nearest £
Last year
to the nearest £
25,000 14,000
-
-
-
-
- 25,000 14,000
0 4,800
- 0 4,800
25,000 18,800
240 265
1473 848
6708 21,306
924 900
10,800
- 9,345 34,119
-
- - -
- 9,345 34,119
- 15,655 -15,319
4,755 20,074
- 20,410 4,755

Unrestricted Restricted funds funds to nearest £ to nearest £ 20,410 Total cash funds 20,410 - (agree balances with receipts and payments account(s)) OK OK Unrestricted Restricted funds funds to nearest £ to nearest £

Fund to which

asset belongs Cost (optional)

Fund to which

asset belongs Cost (optional)

Fund to which
Amount due
liability relates
(optional)
Fund to which
Amount due
liability relates
(optional)
Fund to which
Amount due
liability relates
(optional)
ature
Print Name
E MARSHALL

2

CHARnY COMMISSION Recel For thg poriQ Sectlon A Recelpts and payments Al Roc rants AHJ un r•c•i 265 '4PheJsrt9 f X 695 ReP&Yrne￿t for luTrJ¥ recelved J4,119 A4 A6s•1 and In¥•￿m• AS 1 A6 Ca¥h C•sh lunds thi¥ •rnl Section B Statefnent of a55et5 and l i

-15,319

0

OK

Endowment funds to nearest £

----- Start of picture text -----
-
----- End of picture text -----

Endowment

funds

to nearest £

Current value

(optional)

Current value

(optional)

When due

(optional)

Date of approval 9/18/2026

9/18/2026

Socil IJKAOS monts accounls I tsand CC10a 01-J￿-2￿ 31 tJ¢ 74 funds Total .oo• fi.QDU 265 90D )4.119 10.420 Y.119 bililies at the end of Ihe perlod fuivJ• I￿5￿ fvnaT5 4.755 Vnwèstskted turMI Retrl<ie

Fwnd Pnnt Trlame E laARSHALL 24110.202J ¥Jtlf43025

2025 Incom

Income and Expenditure Account UK Acute Oncol

Income from Donations

Income from Donations
Date Category
1/28/2025 Income
4/24/2025 Income
8/1/2025 Income
12/19/2025 Income
12/22/2025 Income
Total Result

Expenditure from Donations

Expenditure from Donations Expenditure from Donations
cleaned narrative Date
Outward Faster Payment – Media 1productions 12/16/2025
Account to Account Transfer – SAWIN & EDWARDS LLP 11/6/2025
Outward Faster Payment – Frank Design Ltd 11/6/2025
Online Banking Monthly Fee 1/31/2025
2/28/2025
3/28/2025
4/28/2025
5/28/2025
6/27/2025
7/28/2025
8/28/2025
9/26/2025
10/28/2025
11/28/2025
12/24/2025
Total Result

me and Expenditure Account

ogy Society (UKAOS)

cleaned narrative Sum of Mone
Inward Payment – GILEAD SCIENCES LTD(ref: 012/11.12.2024) 4000
BACS Payment Received – DAIICHI(0150000359) 4000
Inward Payment – CAREOLOGY HEALTH LIMITED 500
BACS Payment Received – BIOMERIEUX UK LTD(00072000318198) 12500
BACS Payment Received – ASTRAZENECA UK LIM(INV/106625779) 4000
25000
Category Sum of Mone
Secretariate 6708
Audit Costs 1473
WebSite 924
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
Bank Fees 20
9345
Opening Bank Balance (1/1/25) 4755.4
Income 25000
ey In (£) Expenditure 9345
Closing Bank Balance 20410.4

ey Out (£)

Account5tu*•m•nt ETRO BANK J1 JAN2D2 £4 Y554ts SortC4 rdb

Source: Ban

Date

1/31/2025 2/28/2025 3/28/2025 4/28/2025 5/28/2025 6/27/2025 7/28/2025 8/28/2025 9/26/2025 10/28/2025 11/28/2025 12/24/2025 1/28/2025 4/24/2025 8/1/2025 12/19/2025 12/22/2025 11/6/2025 11/6/2025 12/16/2025

nak Statements

Description Online Banking Monthly Fee [eu-prod.as...rosoft.com] Online Banking Monthly Fee [eu-prod.as...rosoft.com] Online Banking Monthly Fee [statement-...25-January | PDF] Online Banking Monthly Fee [statement-...5-February | PDF] Online Banking Monthly Fee [statement-2025-March | PDF] Online Banking Monthly Fee [statement-2025-April | PDF] Online Banking Monthly Fee [statement-2025-May | PDF] Online Banking Monthly Fee [statement-2025-June | PDF] Online Banking Monthly Fee [statement-2025-July | PDF] Online Banking Monthly Fee [statement-...025-August | PDF] Online Banking Monthly Fee [statement-...-September | PDF] Online Banking Monthly Fee [statement-...25-October | PDF] Inward Payment – GILEAD SCIENCES LTD (ref: 012/11.12.2024) [eu-prod.as...rosoft.com] BACS Payment Received – DAIICHI (0150000359) [statement-...5-February | PDF] Inward Payment – CAREOLOGY HEALTH LIMITED [statement-2025-June | PDF] BACS Payment Received – BIOMERIEUX UK LTD (00072000318198) [statement-...25-October | PDF] BACS Payment Received – ASTRAZENECA UK LIM (INV/106625779) [statement-...25-October | PDF] Account to Account Transfer – SAWIN & EDWARDS LLP (UKAOS) [statement-...-September | PDF] Outward Faster Payment – Frank Design Ltd [statement-...-September | PDF] Outward Faster Payment – Media 1 productions [statement-...25-October | PDF]

Money In (£) Money Out (£) Balance After (£) Category
0 20 8735.4 Bank Fees
0 20 8715.4 Bank Fees
0 20 8695.4 Bank Fees
0 20 12675.4 Bank Fees
0 20 12655.4 Bank Fees
0 20 12635.4 Bank Fees
0 20 12615.4 Bank Fees
0 20 13095.4 Bank Fees
0 20 13075.4 Bank Fees
0 20 13055.4 Bank Fees
0 20 10638.4 Bank Fees
0 20 20410.4 Bank Fees
4000 0 8755.4 Income
4000 0 12695.4 Income
500 0 13115.4 Income
12500 0 16430.4 Income
4000 0 20430.4 Income
0 1473 10658.4 Audit Costs
0 924 12131.4 WebSite
0 6708 3930.4 Secretariate

cleaned narrative Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Online Banking Monthly Fee Inward Payment – GILEAD SCIENCES LTD (ref: 012/11.12.2024) BACS Payment Received – DAIICHI (0150000359) Inward Payment – CAREOLOGY HEALTH LIMITED BACS Payment Received – BIOMERIEUX UK LTD (00072000318198) BACS Payment Received – ASTRAZENECA UK LIM (INV/106625779) Account to Account Transfer – SAWIN & EDWARDS LLP (UKAOS) Outward Faster Payment – Frank Design Ltd Outward Faster Payment – Media 1 productions